Risks and Benefits of Conducting Preclinical Studies in the Global Setting

| 01 December 2011 | By Mukesh KumarJanice Longstreth

It is generally accepted that the preclinical studies needed for first-in-man clinical studies usually take one to three years and cost up to $10 million USD, and the preclinical studies needed for market approval application cost about $70-$90 million.1

 

© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy